BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24614281)

  • 1. Selectivity and potency of microcystin congeners against OATP1B1 and OATP1B3 expressing cancer cells.
    Niedermeyer TH; Daily A; Swiatecka-Hagenbruch M; Moscow JA
    PLoS One; 2014; 9(3):e91476. PubMed ID: 24614281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent cytotoxicity of the phosphatase inhibitor microcystin LR and microcystin analogues in OATP1B1- and OATP1B3-expressing HeLa cells.
    Monks NR; Liu S; Xu Y; Yu H; Bendelow AS; Moscow JA
    Mol Cancer Ther; 2007 Feb; 6(2):587-98. PubMed ID: 17308056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organic anion transporting polypeptides 1B1 and 1B3 play an important role in uremic toxin handling and drug-uremic toxin interactions in the liver.
    Sato T; Yamaguchi H; Kogawa T; Abe T; Mano N
    J Pharm Pharm Sci; 2014; 17(4):475-84. PubMed ID: 25579430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nostocyclopeptide-M1: a potent, nontoxic inhibitor of the hepatocyte drug transporters OATP1B3 and OATP1B1.
    Herfindal L; Myhren L; Kleppe R; Krakstad C; Selheim F; Jokela J; Sivonen K; Døskeland SO
    Mol Pharm; 2011 Apr; 8(2):360-7. PubMed ID: 21214185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence-based assays for the assessment of drug interaction with the human transporters OATP1B1 and OATP1B3.
    Bednarczyk D
    Anal Biochem; 2010 Oct; 405(1):50-8. PubMed ID: 20540932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.
    Gozalpour E; Greupink R; Wortelboer HM; Bilos A; Schreurs M; Russel FG; Koenderink JB
    Mol Pharm; 2014 Jun; 11(6):1844-55. PubMed ID: 24754247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of mitogen-activated protein kinase signaling pathways in microcystin-LR-induced apoptosis after its selective uptake mediated by OATP1B1 and OATP1B3.
    Komatsu M; Furukawa T; Ikeda R; Takumi S; Nong Q; Aoyama K; Akiyama S; Keppler D; Takeuchi T
    Toxicol Sci; 2007 Jun; 97(2):407-16. PubMed ID: 17369605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microcystin LR Shows Cytotoxic Activity Against Pancreatic Cancer Cells Expressing the Membrane OATP1B1 and OATP1B3 Transporters.
    Kounnis V; Chondrogiannis G; Mantzaris MD; Tzakos AG; Fokas D; Papanikolaou NA; Galani V; Sainis I; Briasoulis E
    Anticancer Res; 2015 Nov; 35(11):5857-65. PubMed ID: 26504008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of OATP1B1 and OATP1B3 to the disposition of sorafenib and sorafenib-glucuronide.
    Zimmerman EI; Hu S; Roberts JL; Gibson AA; Orwick SJ; Li L; Sparreboom A; Baker SD
    Clin Cancer Res; 2013 Mar; 19(6):1458-66. PubMed ID: 23340295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of antibiotics that interact with organic anion-transporting polypeptides 1B1 and 1B3 using fluorescent probes.
    Yamaguchi H; Takeuchi T; Okada M; Kobayashi M; Unno M; Abe T; Goto J; Hishinuma T; Shimada M; Mano N
    Biol Pharm Bull; 2011; 34(3):389-95. PubMed ID: 21372390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-lasting inhibitory effects of cyclosporin A, but not tacrolimus, on OATP1B1- and OATP1B3-mediated uptake.
    Shitara Y; Takeuchi K; Nagamatsu Y; Wada S; Sugiyama Y; Horie T
    Drug Metab Pharmacokinet; 2012; 27(4):368-78. PubMed ID: 22240838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of hepatic uptake transporters by flavonoids.
    Mandery K; Balk B; Bujok K; Schmidt I; Fromm MF; Glaeser H
    Eur J Pharm Sci; 2012 May; 46(1-2):79-85. PubMed ID: 22394605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of modulators of the liver-specific organic anion-transporting polypeptides (OATPs) 1B1 and 1B3 from Rollinia emarginata Schlecht (Annonaceae).
    Roth M; Araya JJ; Timmermann BN; Hagenbuch B
    J Pharmacol Exp Ther; 2011 Nov; 339(2):624-32. PubMed ID: 21846839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organic anion transporter 3- and organic anion transporting polypeptides 1B1- and 1B3-mediated transport of catalposide.
    Jeong HU; Kwon M; Lee Y; Yoo JS; Shin DH; Song IS; Lee HS
    Drug Des Devel Ther; 2015; 9():643-53. PubMed ID: 25653502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Original Russian Neurotropic Drugs on Organic Anion Transporting Polypeptides OATP1B1 and OATP1B3.
    Erokhina PD; Abalenikhina YV; Mylnikov PY; Petrov AV; Ganina SO; Konyakhin EA; Shchulkin AV; Yakusheva EN
    Bull Exp Biol Med; 2023 Dec; 176(2):170-175. PubMed ID: 38198100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid isolation of peptidic inhibitors of the solute carrier family transporters OATP1B1 and OATP1B3 by cell-based phage display selections.
    Arita Y; Allen S; Chen G; Zhang W; Wang Y; Owen AJ; Dentinger P; Sidhu SS
    Biochem Biophys Res Commun; 2016 Apr; 473(2):370-6. PubMed ID: 26792727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Okadaic acid is taken-up into the cells mediated by human hepatocytes transporter OATP1B3.
    Ikema S; Takumi S; Maeda Y; Kurimoto T; Bohda S; Chigwechokha PK; Sugiyama Y; Shiozaki K; Furukawa T; Komatsu M
    Food Chem Toxicol; 2015 Sep; 83():229-36. PubMed ID: 26134461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data.
    Kunze A; Huwyler J; Camenisch G; Poller B
    Drug Metab Dispos; 2014 Sep; 42(9):1514-21. PubMed ID: 24989890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naringin attenuates the cytotoxicity of hepatotoxin microcystin-LR by the curious mechanisms to OATP1B1- and OATP1B3-expressing cells.
    Takumi S; Ikema S; Hanyu T; Shima Y; Kurimoto T; Shiozaki K; Sugiyama Y; Park HD; Ando S; Furukawa T; Komatsu M
    Environ Toxicol Pharmacol; 2015 Mar; 39(2):974-81. PubMed ID: 25818985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of three regiospecific amino acid residues is required for OATP1B1 gain of OATP1B3 substrate specificity.
    DeGorter MK; Ho RH; Leake BF; Tirona RG; Kim RB
    Mol Pharm; 2012 Apr; 9(4):986-95. PubMed ID: 22352740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.